Historical analysis of Regeneron Pharmaceuticals income statement accounts such as can show how well Regeneron Pharmaceuticals performed in making a profits. Evaluating Regeneron Pharmaceuticals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Regeneron Pharmaceuticals future profits or losses. Financial Statement Analysis is much more than just reviewing and examining Regeneron Pharmaceuticals latest accounting reports in order to predict its past. Macroaxis encourages investors to analyze financial statement over time for various trends across multiple indicators and accounts to determine whether Regeneron Pharmaceuticals is a good buy for the upcoming year. Additionally take a look at Your Equity Center.
Earning Before Interest and Taxes EBITEarnings Before Interest and Tax is calculated by adding [TaxExp] and [IntExp] back to [NetInc].
Net IncomeNet income is one of the most important fundamental items in finance. It plays a large role in Regeneron Pharmaceuticals financial statement analysis. It represents the amount of money remaining after all of Regeneron Pharmaceuticals operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of [NetIncNCI] from [ConsolInc]; and before the deduction of [PrefDivIS].
RevenuesRevenues refers to the total amount of money received by Regeneron Pharmaceuticals for goods sold or services provided during a certain time period. It also includes all of Regeneron Pharmaceuticals sales as well as any other increase in Regeneron Pharmaceuticals equity.Revenues are reported on Regeneron Pharmaceuticals income statement and calculated before any expenses are subtracted. Amount of Revenue recognized from goods sold; services rendered; insurance premiums; or other activities that constitute an earning process. Interest income for financial institutions is reported net of interest expense and provision for credit losses.
Revenues USD[Revenue] in USD; converted by [FXUSD].